MIRATI THERAPEUTICS INC's ticker is MRTX and the CUSIP is 60468T105. A total of 62 filers reported holding MIRATI THERAPEUTICS INC in Q4 2016. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $1,673,000 | -30.5% | 352,282 | -3.3% | 0.00% | – |
| Q3 2016 | $2,408,000 | +23.2% | 364,284 | +1.7% | 0.00% | – |
| Q2 2016 | $1,955,000 | -74.5% | 358,068 | -0.0% | 0.00% | -100.0% |
| Q1 2016 | $7,663,000 | -28.4% | 358,082 | +5.7% | 0.00% | -50.0% |
| Q4 2015 | $10,705,000 | -3.1% | 338,770 | +5.5% | 0.00% | 0.0% |
| Q3 2015 | $11,047,000 | +320.0% | 320,960 | +284.1% | 0.00% | – |
| Q2 2015 | $2,630,000 | +25.2% | 83,572 | +16.7% | 0.00% | – |
| Q1 2015 | $2,100,000 | +101.1% | 71,620 | +27.0% | 0.00% | – |
| Q4 2014 | $1,044,000 | +2.9% | 56,388 | -2.7% | 0.00% | – |
| Q3 2014 | $1,015,000 | -16.2% | 57,960 | -4.3% | 0.00% | – |
| Q2 2014 | $1,211,000 | +2783.3% | 60,564 | +2623.2% | 0.00% | – |
| Q1 2014 | $42,000 | – | 2,224 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aviva Holdings Ltd. | 3,135,966 | $136,602,679 | 87.83% |
| EcoR1 Capital, LLC | 5,748,399 | $250,400,260 | 8.45% |
| Boxer Capital, LLC | 3,201,440 | $139,454,726 | 7.42% |
| RTW INVESTMENTS, LP | 6,768,514 | $294,836,470 | 6.22% |
| Paradigm Biocapital Advisors LP | 1,668,116 | $72,663,133 | 4.93% |
| Avoro Capital Advisors LLC | 6,666,666 | $290,399,971 | 4.53% |
| Octagon Capital Advisors LP | 655,051 | $28,534,022 | 4.38% |
| Artal Group S.A. | 2,024,226 | $88,175 | 3.78% |
| Ally Bridge Group (NY) LLC | 70,283 | $3,061,527 | 3.59% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 216,000 | $9,404,640 | 3.17% |